Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • FAQs

    Global Organic Infant Formula Market size was valued at USD 22.49 Billion in 2024 and is poised to grow from USD 23.97 Billion in 2025 to USD 39.98 Billion by 2033, growing at a CAGR of 6.6% during the forecast period (2026–2033). 

    The global organic infant formula market is characterized by intense competition, with players striving to gain a competitive edge. Key factors driving competition include product innovation, quality, pricing, distribution networks, and marketing strategies. Partnerships, acquisitions, and collaborations are common strategies employed to expand product portfolios and geographic reach. The competitive landscape is dynamic, influenced by evolving consumer preferences, regulatory developments, and market trends. Companies must continuously adapt their strategies to maintain competitiveness and meet the growing demand for organic infant formula. 'Nestle (Switzerland) ', 'HiPP GmbH & Co. Vertrieb KG (Germany) ', 'Danone (France) ', 'Abbott Laboratories (US) ', 'Holle Baby Food AG (Switzerland) ', 'Bubs Australia Limited (Australia) ', 'Earth's Best Organic (US) ', 'Babybio (France) ', 'Parent's Choice (US) ', 'Lebenswert Bio (Germany) ', 'Kabrita (Netherlands) ', 'Biostime International Holdings Limited (China) ', 'Nature's One (US) ', 'Prolacta Bioscience (US) ', 'The Honest Company (US) ', 'Bobbie (US) '

    The prevalence of health complications such as breast cancer and diabetes has been on the rise, leading to a significant decline in breastfeeding rates in recent years. According to a report from the World Health Organization, approximately 2.3 million women worldwide were diagnosed with breast cancer in 2020, and 685,000 lost their lives to the disease. In the US, breast cancer accounts for 1 in 3 female cancer cases, making it the most common form of cancer globally, representing approximately 12% of all cancer cases each year. This decline in breastfeeding rates is subsequently fueling the demand for organic infant formula.

    Increasing Consumer Awareness: There is a growing awareness among consumers about the benefits of organic infant formula, including its natural and chemical-free composition. This awareness is driving the demand for organic options as parents seek healthier alternatives for their infants.

    North America held the largest share, accounting for 36% of the overall market. The growth in this region can be attributed to various factors, such as negative attitudes toward breastfeeding, a high level of women's participation in household responsibilities, which leaves them with limited time for breastfeeding, inadequate workplace setups or supportive environments for breastfeeding, high disposable incomes, and a lack of awareness regarding the benefits of breastfeeding.

    Feedback From Our Clients

    Global Organic Infant Formula Market

    Report ID: SQMIG30I2284

    $5,300
    BUY NOW